Exclamation marks, ellipses and ‘haha’ can’t fix our growing inability to communicate. By Nitsuh Abebe “How Many Exclamation Points Are Too Many in an Email? A Psychologist Weighs In.” A psychologist!

Does string theory—the controversial “theory of everything” from physics—tell us anything about consciousness and the human brain? If you're enjoying this article, consider supporting our ...

For more than a century, scientists have wondered why physical structures like blood vessels, neurons, tree branches, and other biological networks look the way they do. The prevailing theory held ...

The value of China’s only pure-play silver fund plunged by its maximum daily limit of 10% on Thursday, ending a frenzied bull run that had prompted its manager to issue a rare series of warnings. The ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

A photo is circulating on social media that appears to show President Donald Trump using a walker, but it is AI-generated. The image was originally posted on X by Democratic strategist Keith Edwards, ...

Years ago, an audacious Fields medalist outlined a sweeping program that, he claimed, could be used to resolve a major problem in algebraic geometry. Other mathematicians had their doubts. Now he says ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

College students are being wrongly accused of using AI to cheat on their assignments by their university — based, in a headache-inducing twist, on the findings of another AI system. A student named ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Robin Shields does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...